Skip to main content
Caplight Logo









Hurdle

Hurdle

Private
LondonHealthcare & Life Scienceshttps://hurdle.bio/

Last Round

Seed

Jan 9, 2019

Total Funding Raised

$1.53M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Hurdle is a healthcare technology company that provides a diagnostics-as-a-service platform to facilitate better care, operational optimization, and personalized health interventions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting, Hardware Sales

AI Layer

Infrastructure

Keywords

Diagnostics-as-a-ServiceDaaSdiagnostics infrastructureAI biomarker discoverydiagnostics APIat-home diagnosticsbio-infrastructureHealth Foundation Modelslab testing APIbiomarker discoverywhite-label diagnosticsepigeneticsdiagnostics logisticslab testing networksample collection kitsmulti-omics AIbio foundation model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hurdle Comparables

Compare Hurdle with similar companies based on industry and business-model similarity.

Hurdle comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ash
84%
Remi Health
82%
Innovative Health Diagnostics
81%

Hurdle Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 9, 2019
AcceleratorMar 1, 2018

Key People

Founding team and executive leadership

Rob Thompson

CTO & Co-Founder With

Founding Team

Rupert Channing

Advisor To Chief Executive Officer, Senior Commercial Advisor

Executive Team

Tom Stubbs

CEO

Executive Team

Gordon McCulloch

CFO

Executive Team

Hurdle Investors

Notable investors and investment history

Hurdle investors
InvestorRounds
AnthemisSeed
SOSVAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 38% MoM.

  • Jan 30, 2026

    Monthly visitors grew 79% MoM.

Hurdle Filings

Explore SEC and related filing metadata, where available.

Hurdle filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hurdle's valuation, stock price, and market status.

Is Hurdle a public or private company?

Hurdle is a private company.

What is the current stock price of Hurdle?

Hurdle is a private company with no public stock price. No recent secondary market data is available.

How much is Hurdle worth (valuation)?

Valuation information for Hurdle is not publicly available.

Can I buy Hurdle stock?

Hurdle shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hurdle's last funding round?

Hurdle's most recent funding round was Seed on January 9, 2019.

Who are the main investors in Hurdle?

Key investors in Hurdle include Anthemis, SOSV.

Will Hurdle IPO soon?

No public IPO plans have been announced for Hurdle.

How can I track Hurdle secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hurdle's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range28
Year Founded2017
Last FundingJan 9, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?